Elekta

Elekta is a global pioneer in precision radiation therapy and one of China's smart radiotherapy ecosystems. Founded in 1972 and headquartered in Stockholm, Sweden, Elekta's founder, Professor Lars Leksell, invented the world's first Gamma Knife and is hailed as a "scientific master who changed history." With the mission of "Hope for everyone dealing with cancer," Elekta provides precise, intelligent, and personalized holistic radiation therapy solutions to medical institutions and patients worldwide, ensuring that every cancer patient in the world has the opportunity to receive high-level treatment and care.

For over 50 years, Elekta has continued to innovate, constantly pushing the boundaries of science and medicine, and always leading the industry to new heights. Currently, Elekta serves over 7,000 medical institutions in more than 120 countries and regions, providing high-level smart radiotherapy services to over 2 million cancer patients annually.

Since pioneering its entry into China in 1982 and continuously deepening its presence in the Chinese market, Elekta's precision smart radiotherapy holistic solutions cover linear accelerators (Elekta Linacs), high-field magnetic resonance-guided radiotherapy systems (Elekta Unity), brachytherapy, neuroscientific solutions, oncology information management systems, and full life-cycle services, while proactively collaborating with industry partners to build a smart radiotherapy ecosystem.

Elekta continues to increase investment in production, R&D, and talent development. Currently, it has its largest global R&D and production base in Beijing and Shanghai, and its second-largest software R&D center worldwide. While enhancing local R&D and production capabilities, it creates solutions better suited to Chinese users and patients, and provides high-quality radiotherapy products and services of global unified standards to Chinese and global users, achieving "Chinese wisdom serving the world"! In addition, as the first domestic research institute dedicated to radiotherapy, Elekta Radiotherapy Research Institute promotes high-quality talent development, clinical applications, and research in China through innovative development, clinical research, talent training, and academic cooperation, helping to solidify China's international influence and position in radiotherapy!

Elekta has embarked on a new journey of deepening its presence in China for the next 40 years. It will continue to actively implement the national strategy of "facing people's life and health," work with the government, industry, and partners from all walks of life to achieve the goals of the "Healthy China 2030" strategy, contribute more Chinese wisdom and solutions to the world, promote the building of a global community of health for all, and bring the light of hope to more cancer patients!